Esperas Pharma Overview

  • Founded
  • 2015
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Esperas Pharma General Information


Operator of a medical technology platform intended to offer biopharmaceutical products. The company's platform engages in developing an oral investigational medicine which specifically inhibits cancer cell division or unchecked proliferation, enabling healthcare professionals to avail a number of additional cancer indications with the goal of providing a clinical proof-of-concept of efficacy for cancer patients.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Montreal, Quebec
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Esperas Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 000.00 Completed Out of Business
1. Early Stage VC 13-Apr-2015 000.00 000.00 Completed Startup
To view Esperas Pharma’s complete valuation and funding history, request access »